skip to Global Navigation Bar skip to main content


homeHome > Press Release > News

News

News Content
Seoul National University Hospital ? Daewoong Pharmaceuticals sign MOU to commercialize stem cell treatment
Date 2016-06-28 Hit 6115
list
News List
Prev Daewoong Pharmaceuticals presents result of phase 3 clinical trial on Supect at The Korean Society of Hematology
Next Daewoong Pharmaceuticals holds a symposium to promote the excellence of Olmesartan medications including ‘Olmetec’ at International Society of Hypertension